Prudent Man Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-5,051
Closed -$271K – 195
2023
Q3
$271K Sell
5,051
-173
-3% -$9.22K 0.11% 142
2023
Q2
$282K Hold
5,224
– – 0.11% 146
2023
Q1
$284K Hold
5,224
– – 0.11% 145
2022
Q4
$253K Buy
+5,224
New +$229K 0.1% 159
2022
Q2
– Sell
-4,098
Closed -$210K – 183
2022
Q1
$210K Hold
4,098
– – 0.09% 174
2021
Q4
$205K Sell
4,098
-818
-17% -$40.5K 0.08% 179
2021
Q3
$237K Hold
4,916
– – 0.09% 172
2021
Q2
$259K Buy
4,916
+37
+0.8% +$1.93K 0.1% 166
2021
Q1
$241K Sell
4,879
-4
-0.1% -$192 0.1% 169
2020
Q4
$237K Hold
4,883
– – 0.1% 157
2020
Q3
$245K Sell
4,883
-76
-2% -$3.91K 0.13% 136
2020
Q2
$253K Buy
+4,959
New +$241K 0.22% 117

Other funds holding SNY

Prudent Man Advisors's SNY Position: Q4 2023 in Review

Prudent Man Advisors sold out of Sanofi (SNY) in Q4 2023, closing a stake of 5,051 shares — an estimated $271K sold.

Prudent Man Advisors first reported a position in SNY in Q2 2020 and held it in 12 quarters. The position peaked at $284K in Q1 2023. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

  • Prudent Man Advisors reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
  • Prudent Man Advisors sold 5,051 Sanofi shares in Q4 2023, an estimated $271K.
  • Prudent Man Advisors first reported a position in Sanofi in Q2 2020 and held it in 12 quarters.
  • Prudent Man Advisors's Sanofi position peaked at $284K in Q1 2023.
  • 709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Prudent Man Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.